from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0458/-

LFCtreatmentdescriptionclass of inhibitor

-0.653

Amikacinug/mL Amikacintranslation

-1.303

Cap5-10ug/mL Capreomycintranslation

-1.115

Rox10-50 ug/mL Roxithromycintranslation

-0.813

SM2-5 ug/mL Streptomycintranslation

0.323

Tet5-10 ug/mL Tetracyclinetranslation

0.584

Rif0.2-5ug/mL Rifampicintranscription

-0.169

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.316

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.379

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.351

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.914

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.185

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.056

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.991

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.529

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.176

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.267

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.711

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.234

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.186

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.122

KCN5-20 ug/mL Potassium cyaniderespiration

-0.187

NaN30.2-2 mM Sodium aziderespiration

-1.253

Nigericin50 uM Nigericinrespiration

0.267

TRC10-150 ug/mL Triclosanrespiration

1.358

TRZ10-25 ug/mL Thioridazinerespiration

-0.509

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.469

menadione6-10 ug/mL Menadionerespiration

-0.243

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.112

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.552

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.567

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.958

NRP_1Non-replicating persistence stage 1dosRassociated

-0.436

Amp0.2mg/mL AmpicillincellWall

-0.359

Cephalexin20-100 ug/mL CephalexincellWall

-0.857

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.393

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.465

EMB10-20 ug/mL EthambutolcellWall

-0.747

Eta12-40 ug/mL EthionamidecellWall

-0.600

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.631

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.399

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.368

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.306

BZA0.12 mg/mL BenzamidearomaticAmides

0.783

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.545

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.056

H2O24 mM hydrogen peroxideDNAdamaging

-0.070

Levo10 ug/mL LevofloxacinDNAdamaging

0.039

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.080

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.210

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.273

UVUV-irradiationDNAdamaging

-0.104

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.282

Antimycin12.5-50 ug/mL Antimycin A?

-0.180

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.423

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.981

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.591

PA8240.2-2 ug/mL PA-824?

-1.505

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.179

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.474

Verapamil50 uM Verapamil?

-0.163

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.589

methoxatin10-20 ug/mL Methoxatin?